Loading...
Please wait, while we are loading the content...
Similar Documents
Platelet glycoprotein IIb/IIIa inhibitors.
| Content Provider | Semantic Scholar |
|---|---|
| Author | Hellstrom, Harold Richard |
| Copyright Year | 2003 |
| Abstract | To the Editor: Platelet glycoprotein (GP) IIb/IIIa antagonists only prompt an overall 8.5% relative reduction in 30-day deaths or myocardial infarction in acute coronary syndromes (ACS),1 and Quinn et al1 suggested that this limited benefit may be due to factors such as antagonist-induced platelet activation. I suggest that limited benefits of GP IIb/IIIa inhibition are due basically to limited participation of platelets in ACS, although negative effects described by Quinn et al1 are no doubt operative. Cases of ACS … |
| File Format | PDF HTM / HTML |
| DOI | 10.1161/01.CIR.0000053955.01455.5A |
| Alternate Webpage(s) | http://circ.ahajournals.org/content/circulationaha/107/5/e39.full.pdf?download=true |
| PubMed reference number | 12578891 |
| Alternate Webpage(s) | https://doi.org/10.1161/01.CIR.0000053955.01455.5A |
| Journal | Medline |
| Volume Number | 107 |
| Issue Number | 5 |
| Journal | Circulation |
| Language | English |
| Access Restriction | Open |
| Content Type | Text |
| Resource Type | Article |